Title
Category
Credits
Event date
Cost
Recorded Controlled Substances: Prescribing and Dispensing Within the Law
  • COACH
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 ACPE Technician
  • 1.00 BDEA
$0.00
This course provides a comprehensive review of the laws and regulations under the Controlled Substances Act of 1970, which mandate that such substances be prescribed solely for legitimate medical purposes by practitioners operating within the scope of their professional practice.
Alabama’s Prescription Drug Monitoring Program: The Essentials
  • COACH
  • 1.25 ACPE Pharmacy
  • 1.25 ACPE Technician
$0.00
Correct and complete prescription information is essential to the integrity of the controlled substance database. Incomplete or inaccurate prescription information can result in prescriptions not being transmitted to the controlled substance database, which can cause inaccurate patient records, complications between prescribers and their regulatory boards, and a diminished clinical tool for healthcare providers.
ALAHOPE Recorded Course - Overdose Antidote Therapy
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 ACPE Technician
  • 0.25 ABO
  • 0.25 ABP
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding antidotes for responding to an overdose.
Laws and Rules Governing Pharmacy-Related Entities in Alabama
  • Law
  • 1.50 ACPE Pharmacy
$25.00
This CE presentation reviews Alabama-Specific pharmacy laws, rules, and regulations relevant to the profession including the laws about the pharmacy itself, Pharmacy Benefit Managers, wholesalers, manufacturers, distributors, and other stakeholders important for a pharmacist to know and for review of the MPJE.
Recorded Recent Updates for the Management of Urinary Tract Infections
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
Urinary tract infections (UTIs) are one of the most common infectious diseases in the outpatient, long-term care, and inpatient settings.  In 2025, new treatment guidelines were released that updated the definitions for uncomplicated urinary tract infections (uUTIs) from complicated UTIs (cUTIs), as well as updated the treatment recommendations for cUTIs, such as pyelonephritis.  Healthcare providers must be familiar with these new recommendations to provide the best treatment possible for patients while simultaneously providing appropriate antimicrobial stewardship to minimize the developm

Pages